These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8204502)

  • 1. Interleukin-1.
    Dinarello CA
    Adv Pharmacol; 1994; 25():21-51. PubMed ID: 8204502
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of cytokines in sepsis.
    Hack CE; Aarden LA; Thijs LG
    Adv Immunol; 1997; 66():101-95. PubMed ID: 9328641
    [No Abstract]   [Full Text] [Related]  

  • 3. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock.
    Dinarello CA
    Chest; 1997 Dec; 112(6 Suppl):321S-329S. PubMed ID: 9400897
    [No Abstract]   [Full Text] [Related]  

  • 4. Modulation of cytokine responses in sepsis.
    Lowry SF; Moldawer LL
    Ann N Y Acad Sci; 1993 Jun; 685():471-82. PubMed ID: 8363256
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytokines as mediators in the pathogenesis of septic shock.
    Dinarello CA
    Curr Top Microbiol Immunol; 1996; 216():133-65. PubMed ID: 8791739
    [No Abstract]   [Full Text] [Related]  

  • 6. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy.
    Yoon BH; Jun JK; Romero R; Park KH; Gomez R; Choi JH; Kim IO
    Am J Obstet Gynecol; 1997 Jul; 177(1):19-26. PubMed ID: 9240577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic control of the tumor necrosis factor and interleukin-1 signaling cascade.
    Stewart RJ; Marsden PA
    Am J Kidney Dis; 1995 Jun; 25(6):954-66. PubMed ID: 7771496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of interleukin-1 and tumor necrosis factor in lipopolysaccharide-induced hypoglycemia.
    Vogel SN; Henricson BE; Neta R
    Infect Immun; 1991 Jul; 59(7):2494-8. PubMed ID: 1828792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways.
    Carlson NG; Wieggel WA; Chen J; Bacchi A; Rogers SW; Gahring LC
    J Immunol; 1999 Oct; 163(7):3963-8. PubMed ID: 10490998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms underlying the actions of the pro-inflammatory cytokine interleukin 1. Royal Irish Academy Medal Lecture.
    O'Neill LA
    Biochem Soc Trans; 1997 Feb; 25(1):295-302. PubMed ID: 9056887
    [No Abstract]   [Full Text] [Related]  

  • 11. The interleukin-1 family.
    Roux-Lombard P
    Eur Cytokine Netw; 1998 Dec; 9(4):565-76. PubMed ID: 9889400
    [No Abstract]   [Full Text] [Related]  

  • 12. Involvement of tumor necrosis factor-alpha, interleukin-1 beta, interleukin-8, and interleukin-1 receptor antagonist in acute lung injury caused by local Shwartzman reaction.
    Imamura S; Matsukawa A; Ohkawara S; Kagayama M; Yoshinaga M
    Pathol Int; 1997 Jan; 47(1):16-24. PubMed ID: 9051688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor alpha is a key mediator of gut inflammation seen in amebic colitis in human intestine in the SCID mouse-human intestinal xenograft model of disease.
    Zhang Z; Mahajan S; Zhang X; Stanley SL
    Infect Immun; 2003 Sep; 71(9):5355-9. PubMed ID: 12933883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-1 and tumor necrosis factor and their naturally occurring antagonists during hemodialysis.
    Dinarello CA
    Kidney Int Suppl; 1992 Oct; 38():S68-77. PubMed ID: 1328757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine antagonists in infectious and inflammatory disorders.
    Catania A; Manfredi MG; Airaghi L; Ceriani G; Gandino A; Lipton JM
    Ann N Y Acad Sci; 1994 Nov; 741():149-61. PubMed ID: 7825802
    [No Abstract]   [Full Text] [Related]  

  • 16. Interleukin-1 and tumor necrosis factor: effector cytokines in autoimmune diseases.
    Dinarello CA
    Semin Immunol; 1992 Jun; 4(3):133-45. PubMed ID: 1320950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking interleukin-1 receptors.
    Dinarello CA
    Int J Clin Lab Res; 1994; 24(2):61-79. PubMed ID: 7919431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic regulation of proinflammatory cytokines.
    Watkins LR; Nguyen KT; Lee JE; Maier SF
    Adv Exp Med Biol; 1999; 461():153-78. PubMed ID: 10442173
    [No Abstract]   [Full Text] [Related]  

  • 19. [Intra-tumoral IL-6 down-regulation system as a new therapeutic target to control tumor growth in colorectal carcinoma].
    Miki C; Kusunoki M
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():476-9. PubMed ID: 14574939
    [No Abstract]   [Full Text] [Related]  

  • 20. CMNSG Guest Lecture. Interleukin-1, interleukin-1 receptor, and interleukin-1 receptor antagonist.
    Espat NJ; Rogy MA; Copeland EM; Moldawer LL
    Proc Nutr Soc; 1994 Jul; 53(2):393-400. PubMed ID: 7972153
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.